NCT06405815View on ClinicalTrials.gov

A Radiomic Model for Risk of Local Recurrence and DFS for T3 and T4 Non-small Cell Lung Cancer

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2023

Conditions
Lung Cancer, Nonsmall Cell
Interventions
OTHER

tumor and peritumor radiomic feature

extracted the tumor and peritumor radiomic feature from the preoperative enhanced chest CT

Trial Locations (1)

Unknown

Jinling Hospital, Nanjing

All Listed Sponsors
lead

Jinling Hospital, China

OTHER

NCT06405815 - A Radiomic Model for Risk of Local Recurrence and DFS for T3 and T4 Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter